Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
nutritional and metabolic diseases
MeSH D009750 - nutritional and metabolic diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009750:
Nutritional and metabolic diseases
6 Companies
6 Drugs
$
Success rate
D008659:
Metabolic diseases
1 Company
2 Drugs
$
Success rate
D009748:
Nutrition disorders
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/1
Phase 2
0
%
0/2
Phase 3
67
%
2/3
Approved:
2
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AstraZeneca
Dapagliflozin
,
Saxagliptin
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use